MEKESHA SENTER: Open Payments
NPI 1679114953 · WILKESBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,584 in 97 payments from 17 companies in 2025. Trend: 2023 $2,617 · 2024 $1,804 · 2025 $1,584
Food & beverage: $1,584
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 30 | $370 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 12 | $243 |
| AstraZeneca Pharmaceuticals LP | 10 | $198 |
| PFIZER INC. | 11 | $162 |
| Lilly USA, LLC | 8 | $134 |
| Abbott Laboratories | 4 | $107 |
| Novo Nordisk Inc | 5 | $79 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 5 | $77 |
| Baxter Healthcare | 2 | $51 |
| Novartis Pharmaceuticals Corporation | 2 | $32 |
Products named: JARDIANCE, UBRELVY, QULIPTA, ELIQUIS, FREESTYLE LIBRE 3, MOUNJARO, CAPLYTA, AIRSUPRA.
Industry payments across NC — which companies pay providers there.
